Results

Total Results: 441 records

Showing results for "lee".

21. App-E-Surv-Report-1-Nonopioid-Pharmacol-Chronic-Pain (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-surv-report-1-nonopioid-pharmacol-chronic-pain.xlsx
    September 20, 2022 - Amitriptyline 25 mg 12 None Lee, 2020 Korea Head-to-head Fair NPP (DPN and PHN) Age, mean: 63 Female

22. App-F2-Surv-Report-2-Nonopioid-Pharmacol-Chronic-Pain (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f2-surv-report-2-nonopioid-pharmacol-chronic-pain.xlsx
    September 20, 2022 - 60 mg/day 12 Short NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR Somnolence 3 43 43 NR NR NR Lee … PGB Pregabalin CR 12 Short 14 176 3 176 NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR Lee

23. Appendix F (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/Appendix%20F.xlsx
    November 04, 2021 - overall attrition over 4 years Yes Yes Moderate Gruber, 2021 No No Unclear No Yes No Yes Yes High Lee

24. Appendix F 0 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/Appendix%20F_0.xlsx
    November 04, 2021 - overall attrition over 4 years Yes Yes Moderate Gruber, 2021 No No Unclear No Yes No Yes Yes High Lee

25. Cannabis-App-G1-2-Tables-Surveillance-Report-2 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-g1-2-tables-surveillance-report-2.xlsx
    January 22, 2022 - overall attrition over 4 years Yes Yes Moderate Gruber, 2021 No No Unclear No Yes No Yes Yes High Lee

26. Pbt-Lsr-Draft-Rob (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/pbt-lsr-draft-rob.xlsx
    March 15, 2022 - overall attrition over 4 years Yes Yes Moderate Gruber, 2021 No No Unclear No Yes No Yes Yes High Lee

27. Cannabis-App-G-Table-Surveillance-Report-2 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-g-table-surveillance-report-2.xlsx
    February 16, 2022 - overall attrition over 4 years Yes Yes Moderate Gruber, 2021 No No Unclear No Yes No Yes Yes High Lee

28. Cannabis-Annual-Update2-Table-F1 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-annual-update2-table-f1.xlsx
    March 13, 2023 - overall attrition over 4 years Yes Yes Moderate Gruber, 2021 No No Unclear No Yes No Yes Yes High Lee

29. Cannabis-2022-Surv-Rep-3-App-G (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-app-G.xlsx
    January 01, 2022 - overall attrition over 4 years Yes Yes Moderate Gruber, 2021 No No Unclear No Yes No Yes Yes High Lee

30. Cannabis-2022-Update-Surv-Rep-1-Apps-G1-2 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-update-surv-rep-1-apps-G1-2.xlsx
    January 01, 2022 - overall attrition over 4 years Yes Yes Moderate Gruber, 2021 No No Unclear No Yes No Yes Yes High Lee

31. Cer-250-Cannabis-Tables-F1-F2-2022-Update 0 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-tables-f1-f2-2022-update_0.xlsx
    January 01, 2022 - overall attrition over 4 years Yes Yes Moderate Gruber, 2021 No No Unclear No Yes No Yes Yes High Lee

32. Cannabis-App-G-Table-Surveillance-Report-2 0 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-app-g-table-surveillance-report-2_0.xlsx
    February 16, 2022 - overall attrition over 4 years Yes Yes Moderate Gruber, 2021 No No Unclear No Yes No Yes Yes High Lee

33. Cannabis-2023-Surv-Rep-1-App-G (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-1-app-G.xlsx
    January 01, 2023 - overall attrition over 4 years Yes Yes Moderate Gruber, 2021 No No Unclear No Yes No Yes Yes High Lee

34. Cannabis-2022-Surv-Rep-4-Tables-G1-2 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-tables-G1-2.xlsx
    January 01, 2022 - overall attrition over 4 years Yes Yes Moderate Gruber, 2021 No No Unclear No Yes No Yes Yes High Lee

35. Cannabis-2023-Surv-Rep-4-Tables-F1-F-2 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-tables-F1-F-2.xlsx
    January 01, 2023 - overall attrition over 4 years Yes Yes Moderate Gruber, 2021 No No Unclear No Yes No Yes Yes High Lee

36. App-F2-Surv-Report-3-Nonopioid-Pharmacol-Chronic-Pain (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f2-surv-report-3-nonopioid-pharmacol-chronic-pain.xlsx
    September 20, 2022 - 60 mg/day 12 Short NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR Somnolence 3 43 43 NR NR NR Lee … PGB Pregabalin CR 12 Short 14 176 3 176 NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR NR Lee

37. App-F1-Surv-Report-3-Nonopioid-Pharmacol-Chronic-Pain (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f1-surv-report-3-nonopioid-pharmacol-chronic-pain.xlsx
    September 20, 2022 - -1.76 NR NR NR NR 167 172 Treatment difference in favor of group 1 0.17 95% CI NR -0.62 0.29 0.47 Lee … 167 167 Langford, 2013 Good NPP (MS) Placebo Placebo ≥30% improvement on NRS 14 Short 77 172 172 Lee … , 2020 Fair NPP (DPN/PHN) PGB/GBP Pregabalin CR ≥30% improvement on DPRS 12 Short 93 130 176 Lee, 2020 … Fair NPP (DPN/PHN) PGB/GBP Pregabalin IR ≥30% improvement on DPRS 12 Short 91 131 176 Lee, 2020 Fair … NPP (DPN/PHN) PGB/GBP Pregabalin CR ≥50% improvement on DPRS 12 Short 62 130 176 Lee, 2020 Fair NPP

38. Draft-Living-Review-Plant-Chronic-Pain-F-Risk-Of-Bias (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/draft-living-review-plant-chronic-pain-f-risk-of-bias.xlsx
    January 01, 2023 - 2021 No No Unclear No Yes No Yes Yes High Holt, 2023 Yes Yes Yes Unclear No Unclear Yes Yes Moderate Lee

39. App-E-Surv-Report-2-Nonopioid-Pharmacol-Chronic-Pain (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-surv-report-2-nonopioid-pharmacol-chronic-pain.xlsx
    September 20, 2022 - Duloxetine 60 mg 12 None Lee, 2020 Korea Head-to-head Fair NPP (DPN and PHN) Age, mean: 63 Female:

40. Outcomes in COPD patients treated with theophylline (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/decide16final-mortality-risk-in-copd-pts-using-theophylline.pdf
    December 01, 2009 - This report has been published in edited form: Lee TA, Schumock GT, Bartle B, et al. … Suggested citation: Lee TA, Schumock GT, Bartle B, et al. … Lee, Pharm.D., Ph.D. a,b,c Glen T. Schumock, Pharm.D.c Brian Bartle, M.P.H.a A. … Lee TA, Weiss KB. … Lee TA, Pickard AS, Au DH, et al.